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INTRODUCTION 
Global Surveillance of Antibiotic Resistance 
conducted by the World Health Organization (WHO) 
shows an increase in the incidence of antibiotic 
resistance from 2013 to 2014 on the Asian 
continent. Southeast Asia is one region that has a 
high prevalence of antibiotic resistance and occurs in 
almost all classes of antibiotics (World Health 
Organization, 2013). Antibiotic resistance is the 
ability of a microorganism to fight or resist the 
effects of one or more antibiotics (World Health 
Organization, 2015). Resistance can occur in cases of 
different infectious diseases or bacteria.  
Research conducted in Indonesia in the period 1998-
1999 showed for Salmonella spp. experience 
resistance to several antibiotics such as ampicillin 
(7%), chloramphenicol (15%), tetracycline (20%), 
cotrimoxazole (10%), ceftriaxone (2%), kanamycin 
(10%), norfloxacin (1%), cephalothin (7%), neomycin 
(3%) (Lestari, Severin & Verbrugh, 2012). Several 
factors are thought to be the cause of resistance, 
including bacterial gene mutations, horizontal gene 
transfer between bacterial species, and 
inappropriate use of antibiotics. 
In addition to the things mentioned above, several 
studies show that there is a relationship between 
antibiotic resistance and antibiotic use over a certain 
period (prior antibiotic use) before the patient 
diagnosed with resistance. Research conducted by 
Kuster et al. (2014) showed that prior antibiotic use 
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A WHO’s Global Surveillance of Antibiotic Resistance showed there is an 
increase of antimicrobial resistance in Asia between 2013 until 2014. Many 
studies showed that there is a correlation between prior antibiotic use with 
antimicrobial resistance case. The primary objective of this study is to analyze 
the relationship between prior antibiotic use with antimicrobial resistance. İt 
was a retrospective and descriptive study conducted at Bangil Regional 
General Hospital. The data collected from the medical record and 
microbiological test from the patient at the internal ward. Chi-square analysis 
used for the statistic. This study showed that prior antibiotic use increased 
0,399 bigger for antimicrobial resistance rate (p=0,001). 
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has a relationship with the occurrence of resistance 
in a patient at three months after the last time using 
the antibiotic in question. 
Research on this subject is very little, so the authors 
are interested in observing this because knowing the 
presence or absence of the influence of prior 
antibiotic use on the occurrence of resistance can 
help the clinician in determining which therapy is 
more appropriate for the patient. The use of 3 
months as a reference from the time of last antibiotic 
use was due to a study conducted by Kuster et al. 
(2014), which showed that the possibility of 
resistance from an antibiotic to return to baseline 
level was 90 days after the last dose gave to patients. 
RESEARCH METHODS 
This study is retrospective and descriptive. Data 
obtained from medical records and bacterial culture 
results of all internal medicine patients in Bangil  
Regional General Hospital in July to December 2016.  
Based on medical records obtained and then traced 
to patients diagnosed with an infection and using 
antibiotics so that patients who had infections but 
did not get antibiotics and outpatients included in the 
exclusion criteria in this study. Patients who are 
known to have an infection and get antibiotics will 
then be traced to a history of antibiotic use for three 
months before the patient is admitted to the hospital 
and observed the occurrence of resistance in these 
patients based on the results of the culture.  
The analytical method for proving the relationship 
between antibiotic use after patients hospitalized 
with resistance was tested statistically using the chi-
square method. The results of processing the next 
data will show in tables and diagrams. 
RESULT AND DISCUSSIONS 
Patients who were hospitalized in the internal 
hospital ward Bangil in July to December 2016 
reached 4303 people with the highest number of 
patients, namely 846 people in November and the 
lowest as many as 600 people in July. The total 
patients through BPJS funding were 2348 patients 
(54.57%), private insurance as many as 4 patients 
(0.093%), GAKIN APBD 90 patients (2.1%), Jamkesmas 
2 patients (0.046%), SPM 1247 patients (28 , 98%), 
and general as many as 612 patients (14.22%). 
The value of 54.57% of patients whose funding 
through BPJS resembles the coverage of BPJS in East 
Java Province which amounted to 59.16% in 2016 
(Kementrian Kesehatan Republik Indonesia 
[Kemenkes RI], 2017). The number of patients whose 
funding through BPJS on inpatient wards also 
resembled the coverage of BPJS participation in 2015 
in East Java Province which amounted to 55.95% 
(Kemenkes RI, 2017). 
The most common diagnosis of the cause of culture is 
Complication of procedures, not elsewhere classified 
as many as 33 patients followed by infection in the 
surgical wound which also includes cesarean surgery 
as many as 30 patients then pneumonia as many as 
19 patients. 
Observations were made regarding the history of 
antibiotic use by patients over the past three months. 
Of the 140 samples, there were 78 samples where 
the patient had a history of antibiotic use in the last 
Culture Diagnosis Total 
The complication of procedures, not elsewhere classified 33 
Infection of obstetric surgical wound 30 
Pneumonia 23 
Osteomyelitis 12 
Cutaneous abscess 9 
Type 2 diabetic with gangrene 7 
Bacteremia 2 
Vulvovaginitis 2 
Rheumatic heart disease 2 
Abses submandibular 1 
Acute pharyngitis 1 
Burn of an unspecified body region 1 
Corneal ulcer 1 
Diare and gastroenteritis presume infectious origin 1 
Fracture 2 
skin ulcer 1 
Urine tract infection, site not specified 1 
Staphylococcal arthritis elbow 1 
Sepsis due to E.coli 1 
Cellulitis 2 
Nontoxic goiter 1 
Meningitis 1 
Laryngeal diphtheria 1 
Intracranial injury, unspecified 1 
Impetigo bullous 1 
Generalized skin eruption due to drugs and medicaments 
taken internally 
1 
Total 140 
Table 1. Antibiotic sensitivity profile in the group of patients with a 
history of antibiotic use over the past three months.  
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three months before the culture was carried out and 
the remaining 62 patients had no history of 
antibiotic use. Patients who have a history of 
antibiotic use in the last three months have 
observed sensitivity. From the results of these 
observations for ceftazidime, antibiotics had the 
highest number of sensitive results (6 samples) while 
for antibiotics that had the highest resistance level 
was cefazolin (14 samples). Cefadroxil is the most 
commonly found antibiotic in the history of 
antibiotic use with as many as 35 samples, but there 
is no sensitivity data from the antibiotic. 
From patients who did not have a history of 
antibiotic use, meropenem became an antibiotic 
with the highest number of sensitive samples as 
many as 59 samples then followed by piperacillin + 
tazobactam and norfloxacin (52 samples) and 
cotrimoxazole (44 samples) 
Based on observations in groups with a history of 
use, antibiotics that showed sensitive results found 
in 15 samples and 54 samples showed resistance. 
The antibiotics that have the most number of 
sensitive samples are ceftazidime with six samples 
while for antibiotics, which show that the most 
resistant amount is cefazolin with 14 samples. 
Sensitivity for groups that do not have history is as 
many as 906 antibiotic samples tested showing 1301 
sensitive and resistant results. The antibiotics that 
showed the most sensitive results were meropenem 
with 59 samples and Ampicillin, showing the most 
resistant results as many as 87 samples. Antibiotic 
sensitivity from history groups with no history 
showed significantly different results where the 
likelihood of antibiotic resistance was higher in the 
history group compared to the group without 
history. It indicated by the calculation of OR from the 
sensitivity of the two groups where the possibility of 
antibiotic resistance in patients who have a history 
of antibiotic use is 0.399 times greater than patients 
without a history of antibiotics (p = 0.001). 
It supported by research conducted by Kuster et al. 
(2014), which showed that antibiotic resistance in 
patients was caused more by patients having a 
history of antibiotic use before being hospitalized. 
Penicillin, cephalosporins, and quinolones decreased 
their resistance faster than with macrolide. 
Antibiotic resistance other than the macrolide can 
reach the baseline level after 90 days after the last 
antibiotic administration. Cephalosporin antibiotics 
mentioned in the study took 17 to 65 days after the 
last administration to return to sensitivity in 
pneumonia patients, whereas macrolide such as 
azithromycin require a longer time of 49-78 days to 
reach back to painful conditions. It needs between 
each antibiotic to reach the half-life of the plasma  
(Bolon, 2009; Ferrero et al., 1990; Foulds, Shepard & 
Johnson, 1990; Humbert, Spyker, Fillastre & Leroy, 
1979; Maholtra et al., 2007) influences the baseline. 
Antibiotics 
Sensitivity 
Sensitive Resistent 
Amikacin 1 - 
Amoxicillin - - 
Ampisillin - - 
Azythromycine - - 
Benzathine Penicillin - - 
Metronidazole - - 
Cefadroxil - - 
Cefazolin 1 - 
Cefixime - - 
Ceftazidime 6 3 
Ceftriaxone 2 - 
Cefuroxime 1 - 
Ciprofloxacine 1 1 
Doxycline - 1 
Gentamicin 3 - 
Total 15 5 
Table 2. Antibiotic sensitivity profiles in the group of patients with a 
history of antibiotic use over the past three months.  
Antibiotic Class Sensitivity 
Sensitive Resistent 
Penicillin 203 352 
Cephalosporin 146 336 
Aminoglycoside 76 117 
Macrolide 34 40 
Amphenicol 20 18 
Carbapenem 59 37 
Lincosamide 25 20 
Streptomycin - - 
Imidazole - - 
Anti TBC 18 6 
Quinolon 155 257 
Others 170 118 
Total 906 1301 
Table 3. Antibiotic sensitivity profile in the patient group without a 
history of antibiotic use in the last three months.  
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Other studies that support this idea include the 
results of a study conducted by Chung et al., (2007), 
wherein the bacterium Haemophilus influenza, the 
resistance level of new amoxicillin will approach the 
baseline after > 12 weeks. In other research, the old, 
low dose and the last time used for amoxicillin in 
urinary tract infections can affect the level of 
resistance, which will only return at baseline after 1-
3 months (Hillier et al., 2007). Other studies say that 
considering the last time given antibiotics 
themselves with what antibiotics will give next 
referring to antibiotics requires time to replenish the 
mucous membrane of the bacteria so that the 
amount will exceed the number of resistant strains 
of the bacteria (Levin & Rozen, 2006). 
CONCLUSION 
This study does have limitations related to the lack 
of data in the medical record related to the history 
of antibiotic use in hospitalized patients but based 
on calculations comparing the antibiotic profile in 
patients with and without a history of antibiotic use 
for the last 3 months shows that patients who have a 
history of antibiotic use over the past 3 months has 
been shown to increase the likelihood of higher 
resistance compared to patients without a history of 
antibiotic use over the past 3 months 
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